Variables | BRCA1/2+ | BRCA1/2− | p value |
---|---|---|---|
Histological type | |||
 Invasive ductal carcinoma | 10 (90.9 %) | 27 (93.1 %) | 0.63 |
 Invasive lobular carcinoma | 0 (0 %) | 1 (3.4 %) |  |
 Medullary carcinoma | 1 (9.1 %) | 1 (3.4 %) |  |
Tumor size | |||
 T1–T2 | 8 (72.7 %) | 19 (65.5 %) | 1.00 |
 T3 | 2 (18.2 %) | (20.7 %) |  |
 T4 | 1 (9.1 %) | 4 (13.8 %) |  |
SBR grade | |||
 I–II | 4 (36.4 %) | 23 (79.3 %) | 0.02 |
 III | 7 (63.6 %) | 6 (20.7 %) |  |
Node involvement | |||
 N− | 5 (45.5 %) | 13 (44.8 %) | 1.00 |
 N+ | 6 (54.5 %) | 16 (55.2 %) |  |
Estrogen receptors status | |||
 ER− | 7 (63.6 %) | 10 (40.0 %) | 0.28 |
 ER+ | 4 (36.4 %) | 15 (60.0 %) |  |
Progesterone receptors status | |||
 PR− | 7 (63.6 %) | 11 (44.0 %) | 0.47 |
 PR+ | 4 (36.4 %) | 14 (56.0 %) |  |
Her2/neu | |||
 Her2− | 5 (62.5 %) | 16 (66.7 %) | 1.00 |
 Her2+ | 3 (37.5 %) | 8 (33.3 %) |  |
Triple negative (ER−, PR− and HER2/neu−) | |||
 Yes | 5 (62.5 %) | 4 (16.7 %) | 0.02 |
 No | 3 (37.5 %) | 20 (83.3 %) |  |